You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
华海药业(600521.SH)料首季净利润增10%-20% 诉讼及仲裁结果存不确定性
阿思达克 04-09 09:57
华海药业(600521.SH)公布,公司在股吧上关注到有消息称「公司缬沙坦美国患者索赔8个亿,官司失败」。公司关注到这个消息後立即开展认真核实,截止目前,公司因缬沙坦杂质事件所引起的多起诉讼事项及山德士仲裁事项仍在推进过程中,案件尚未开庭,诉讼及仲裁结果尚存在不确定性,公司无法准确判断诉讼事件及仲裁事件可能对公司造成的影响。

公司预计,2021年第一季度净利润介乎2.42亿至2.65亿元人民币(下同),按年增长10%-20%。增主要是由於公司出售了参股公司杭州多禧生物科技3.8597%股权。

扣除非经常性损益的净利润预计介乎1.48亿至1.68亿元,按年下降约15%-25%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account